ORKA

ORKA R&D Expenses

$129.03MTTM · USD

Period ending:

ORKA FY R&D ExpensesUSD
ORKA FY R&D Expenses2005-12-31: $0.002006-12-31: $89.37M2007-12-31: $42.65M2008-12-31: $11.03M2009-12-31: $10.01M2010-12-31: $3.11M2011-12-31: $0.002012-12-31: $1.09M2013-12-31: $2.93M2014-12-31: $5.63M2015-12-31: $7.06M2016-12-31: $12.35M2017-12-31: $14.08M2018-12-31: $4.24M2019-12-31: $1.83M2020-12-31: $4.99M2021-12-31: $13.83M2022-12-31: $4.46M2023-12-31: $1.01M2024-12-31: $75.06M2025-12-31: $100.64M$100.64M$0.00
2005-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ORKA r&d expenses history

Research and development spending. The available annual fiscal periods series contains 21 observations from Dec 31, 2005 to Dec 31, 2025.

Oruka Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
100,640,000
75,060,000
1,013,000
4,464,000
13,832,000
4,992,000
1,833,000
4,239,000
14,076,000
12,348,000
7,063,000
5,625,000
2,928,000
1,092,000
0
3,106,000
10,010,000
11,026,000
42,654,000
89,370,000
0

Compare r&d expenses

All ORKA financial metrics · ORKA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.